Tampa Bay Times – April 5
Sure enough, when the list hit my email, health care and financial services were well-represented, including some of the area’s marquee names — Moffitt Cancer Center, Raymond James Financial, PricewaterhouseCoopers.
Bay News 9 – April 4
Researchers from the Moffitt Cancer Center in Tampa got a financial boost Wednesday which will allow them to continue their efforts to prevent and cure the deadly disease.
WTVT – April 3
The Kay Yow Cancer Fund donated $100,000 to the Moffitt Cancer Center for cancer research.
WTSP – April 3
With the women's Final Four in town this weekend, The Kay Yow Cancer Fund and Moffitt Cancer Center are teaming up to fight the disease.
Spectrum News – April 3
The Moffitt Cancer Center received a $100,000 research grant from the Kay Yow Cancer Fund.
Journal of Clinical Pathways – April 3
Journal of Clinical Pathways (JCP) spoke with Karen K Fields, MD, senior member, Breast Medical Oncology; medical director, Clinical Pathways and Value-Based Cancer Care, Moffitt Cancer Center (Tampa, FL).
WTSP – April 3
They've got several stops to make... including middle schools and the Moffitt Cancer Center... while they recognize the championship
Healio – April 2
I agree patients should seek this agent [BAY 2731954] when progressing on LOXO-101 with specific resistance mutations... - Damon Reed, MD, Moffitt Cancer Center
Targeted Oncology – April 1
According to Hatem Soliman, MD, of Moffitt Cancer Center and Research Institute, who presented the findings during the 2019 AACR Annual Meeting, T-VEC was generally well tolerated, and relative dose intensity (RDI) of the chemotherapy approached 100%.
Sarasota Magazine - April 1
Coming Together Against Cancer (CTAC) has announced that four physicians will speak at its upcoming event on Saturday, April 13, from 9-11:30 a.m. at Eloise Werlin Park in Sarasota. They are Dr. Stephen Rosenberg (Moffitt Cancer Center), Dr. Annick Desjardins (Duke Cancer Institute), Dr. Michael Gorin (Johns Hopkins) and Dr. Kenneth Meredith (Sarasota Memorial Cancer Institute).
Cancer Network – April 1
“Many have published data looking at the relationship between attaining a pathologic complete response [pCR] after neoadjuvant chemotherapy, and found that it is associated with an improved prognosis and reduced likelihood of recurrence,” said Hatem Soliman, MD, of the Moffitt Cancer Center in Tampa, Florida.
83 Degrees Media – April 1
“Presently, [Fowler Avenue] is a path for people where they move as quickly as they can through it, though many people use it to get to Moffitt Cancer Center, USF, or Busch Gardens,” Sharpe notes.
Biopharma Dive – March 31
Still, many groups, including the University of Pennsylvania, Seattle Children's Hospital and the Moffitt Cancer Center as well as Baylor and MSK, are advancing early-stage research efforts — some of which have been licensed to biotechs.
Targeted Oncology – March 29
In an interview with Targeted Oncology, Jimmy J. Caudell, MD, PhD, a radiation oncologist at Moffitt Cancer Center, discussed the role of radioactive iodine therapy in patients with DTC. He also highlighted areas of research that may help determine the best treatment regimens and doses for select patients.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.